scholarly journals Modern View on the Problems of the Diagnosis and Treatment of Purulent-inflammatory Diseases and Sepsis in Obstetrics and Gynecological Practice

2021 ◽  
pp. 08-12
Author(s):  
Ostapiuk L
GYNECOLOGY ◽  
2018 ◽  
Vol 20 (6) ◽  
pp. 35-41
Author(s):  
T Yu Pestrikova ◽  
I V Yurasov ◽  
E A Yurasova

Medical, social and economic relevance of inflammatory diseases of the woman's reproductive organs requires a very careful attitude to the diagnosis and treatment of this pathology. The number of patients with genital infections and inflammatory diseases of the pelvic organs can takes the first place in structure of gynecological morbidity, and is 60.4-65.0%, and this fact is not unique to Russia, but all over the world. Incidence rate of inflammatory diseases of the pelvic organs in the first decade of the twenty-first century is increased at 1.4 times in patients who are from 18 to 24 years old and at 1.8 times in patients aged 25-29 years. At the same time, the cost of diagnosis and treatment has increased, reaching 50-60% of the total cost of providing gynecological care for population. The inflammatory diseases of pelvic organs are a collective concept. It includes of various nosological forms. There are numerous contradictions in the views on diagnostic approaches and treatment tactics, the nature of screening and control over the long-term results of treatment, the etiological and pathogenetic significance of various microorganisms found in the genital tract in patients with inflammatory diseases of the pelvic organs. Currently, there are many opinions among specialists about diagnostic approaches and treatment tactics, the type of screening and monitoring the long-term results of treatment, the etiological and pathogenetic role of various microorganisms which can be found in the genital tract in patients with inflammatory diseases. This review presents the results of a modern approach to the diagnosis, management and rehabilitation of patients with inflammatory diseases of the pelvic organs.


2019 ◽  
Vol 12 (1) ◽  
pp. 38
Author(s):  
A. V. Lysenko ◽  
P. V. Lednev ◽  
G. I. Salagaev ◽  
G. V. Sinyavin ◽  
E. V. Barinov ◽  
...  

2014 ◽  
Vol 162 (2) ◽  
pp. 150-162 ◽  
Author(s):  
Frans G.M. Kroese ◽  
Dominique Baeten ◽  
Tom W.J. Huizinga

2020 ◽  
Vol 4 (3) ◽  
pp. 14-26
Author(s):  
Muneeza Munir ◽  
Shabir Hussain ◽  
Rubi Anwar ◽  
Muhammad Waqas ◽  
Jigar Ali

Nanotechnology is involved in the diagnosis and treatment of infectious and inflammatory diseases. It has shown a good role in regenerating, restoring and repairing damaged body parts, such as the heart, lungs and blood vessels. Nanoparticles (NPs) are helpful in osteoblasts formation and also used in the treatment of bone inflammation, skin infections, tuberculosis (TB), human immunodeficiency virus (HIV), Parkinson’s disease, atherosclerosis, cardiovascular and pulmonary diseases. They also assist the anti-inflammatory drugs in penetrating the skin. Platinum nanoparticles (NP) are used in bone allograft and dentistry while silver NPs possess an excellent potential against viruses, fungi and bacteria. For diagnostic purposes, nanoparticles are mostly used in the form of nanorobots, microchips and biosensors. Quantum dots give information about the tumor; the gold nano-particles are ideal to detect the antibodies of hepatitis and also for RNA and DNA delivery. Nanomaterials play an important role in the management of plant diseases and the activation of their defense mechanisms. The NPs of copper and silver are directly toxic to microorganisms while those of zinc, silicon, manganese, copper and boron have a function in host defense as a fertilizer and alter the nutritional status of the crop. Enzyme-based biosensors coated with Ti, Cu, Ag or Au-NPs greatly enhance the sensitivity of diagnostic probes for the detection of plant infections. The nano-Zn products have been effectively used to control viral, fungal, phytoplasma or bacterial diseases in crop plants. Nanoparticles are also used in packing edible food films.


2020 ◽  
Vol 17 (4) ◽  
pp. 789-795
Author(s):  
M. A. Kovalevskaya ◽  
O. V. Donkareva ◽  
O. A. Pererva

Long-term conjunctival infections are challenging for the outpatient ophthalmologist. This is due to significant changes in microflora towards resistant gram-negative bacteria. Long-term conjunctival infections are challenging for the outpatient ophthalmologist. This is due to a significant change in microflora towards resistant gram-negative bacteria. The above studies are based on microbial associations, which are the causes of inflammatory processes, conjunctiva and cornea.Purpose: to increase the effectiveness of the diagnosis and treatment of chronic specific inflammatory diseases of the organs of vision.Patients and methods. The study was conducted in patients with chlamydial infection (n = 589) and included chronic conjunctival infections lasting more than 4 weeks, follow-up of patients with partners, family members for 3 or more years. Results. The study was carried out in patients with chlamydial infection (n = 589) and with chronic infectious diseases that lasted more than 4 weeks, following patients and family members for 3 or more years. During this period, we performed more than 3 studies for each patient — for diagnostic laboratory studies and 2 consecutive controls 1 and 2 months after treatment, mixed infection was detected in 256 people (10 %), the proportion of women was 20–30 years is 67 %, men — 51 %. In 27 % of cases, communities of Ch. trachomatis and Ureaplasma parvum as leading causative agents of the eye infections.Conclusions. Chlamydia is most often found together with Ureaplasma parvum (27 % of cases among mixed infections). Treatment of various forms of chlаmidia infection is carried out with the help of “Floxal” (0.3 % ofloxacin — drops and ointment). 


Sign in / Sign up

Export Citation Format

Share Document